British opponents of gene patenting this week exposed deals that give a
tobacco company exclusive rights to develop and sell vaccines against lung
cancer. “It’s cynical for tobacco companies to profit from diseases that their
own products cause,” says Helen Wallace of GeneWatch. The pressure group
highlights two deals struck by Japan Tobacco, which makes three of the world’s
five top-selling cigarette brands. In one deal, Corixa of Seattle, Washington,
granted Japan Tobacco a licence to develop vaccines based on patented genes that
are uniquely active in lung cancer cells.
To continue reading, today with our introductory offers
Advertisement
More from New Scientist
Explore the latest news, articles and features
ÎçÒ¹¸£Àû1000¼¯ºÏ
Doubts cast over 'wild' claim that magnetic control can turn on genes
News
Comment
The best new science fiction books of May 2026
Culture
ÎçÒ¹¸£Àû1000¼¯ºÏ
The rich but complicated legacy of genome pioneer Craig Venter
News
Physics
We have figured out a new way to send messages into the past
News
Popular articles
Trending New Scientist articles
1
We have figured out a new way to send messages into the past
2
Thought-provoking photographs capture what it feels like to have ADHD
3
100-year-old assumption about the universe may soon be overturned
4
Is consciousness more fundamental to reality than quantum physics?
5
Weird 'transdimensional' state of matter is neither 2D nor 3D
6
The rich but complicated legacy of genome pioneer Craig Venter
7
Ann Leckie continues to shine with new sci-fi novel Radiant Star
8
Why dinosaurs lived much more complex lives than we thought
9
Simple treatment tweak drastically reduces blood loss from severe cuts
10
We may finally have a cure for many different autoimmune conditions
